Protalix BioTherapeutics (PLX) Flat on Presenting Results

by Benzinga Staff
September 7, 2016 10:58 AM | 16 seconds read | Make a Comment

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Protalix BioTherapeutics, Inc. (NYSE MKT: PLX) shares inched up 0.1% to 62 cents, on giving an oral presentation highlighting the results of the phase I/II clinical trial of PRX-102 for the treatment of Fabry disease at a symposium in Rome. Share volume was 160,000, compared to an all-day average of 119,000

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.